Sepsis Research Today is a free monthly online journal that collates and summarizes the latest research about Sepsis, including details on septicemia, diagnosis, symptoms, treatment.

Volume 4 (2007), Issue 10 (October)

1. Daptomycin in the treatment of bacteremia.
   Am J Med, 120(10): S21-7. [Abstract] [Full-text]
2. Two rare severe and fulminant presentations of Q fever in patients with minimal risk factors for this disease.
   Intern Med J, 37(11): 775-8. [Abstract] [Full-text]
3. Endotoxemia and sepsis mortality reduction by non-anticoagulant activated protein C.
   J Exp Med, 204(10): 2439-48. [Abstract] [Full-text]
4. Plasma thrombin activatable fibrinolysis inhibitor and tissue factor pathway inhibitor changes following sepsis.
   Clin Appl Thromb Hemost, 13(4): 362-8. [Abstract] [Full-text]
5. Risk factors associated with methicillin-resistant Staphylococcus aureus infection in patients admitted to the ED.
   Am J Emerg Med, 25(8): 880-6. [Abstract] [Full-text]
6. Bacterial endotoxin: a trigger factor for alcoholic pancreatitis? Evidence from a novel, physiologically relevant animal model.
   Gastroenterology, 133(4): 1293-303. [Abstract] [Full-text]
7. Cellular immunity and active human cytomegalovirus infection in patients with septic shock.
   J Infect Dis, 196(9): 1288-95. [Abstract] [Full-text]
8. In vitro activity of daptomycin and tigecycline against coagulase-negative staphylococcus blood isolates from bone marrow transplant recipients.
   Eur J Haematol, 79(5): 405-9. [Abstract] [Full-text]
9. New therapies for sepsis: focus on the interleukin (IL)12 family member IL27.
   Ann Rheum Dis, 66: iii29-31. [Abstract] [Full-text]
10. Severe septic inflammation as a strong stimulus of myocardial NT-pro brain natriuretic peptide release.
    Int J Cardiol, 122(2): 131-6. [Abstract] [Full-text]
11. Common TNF-alpha, IL-1 beta, PAI-1, uPA, CD14 and TLR4 polymorphisms are not associated with disease severity or outcome from Gram negative sepsis.
    BMC Infect Dis, 7: 108. [Abstract] [Full-text]
12. Effects of low dose endotoxemia on endothelial progenitor cells in humans.
    Atherosclerosis, 195(1): e202-6. [Abstract] [Full-text]
13. Carbon monoxide in sepsis.
    Antioxid Redox Signal, 9(11): 2013-26. [Abstract] [Full-text]
14. Role of oxidants in lung injury during sepsis.
    Antioxid Redox Signal, 9(11): 1991-2002. [Abstract] [Full-text]
15. Fooling others or oneself? A history of therapeutic fads and its current relevance.
    Psychiatr Q, 78(4): 287-93. [Abstract] [Full-text]
16. Drotrecogin alpha (activated): the treatment for severe sepsis?
    Expert Opin Biol Ther, 7(11): 1763-77. [Abstract] [Full-text]
17. Rapid fluid resuscitation in pediatrics: testing the American College of Critical Care Medicine guideline.
    Ann Emerg Med, 50(5): 601-7. [Abstract] [Full-text]
18. The transient receptor potential vanilloid 1 (TRPV1) receptor protects against the onset of sepsis after endotoxin.
    FASEB J, 21(13): 3747-55. [Abstract] [Full-text]

© 2004-2008 Sepsis Research Today. All Rights Reserved.